Within the Pharmaceutical Industry, PORIB has been working with different units responsible for demonstrating the value of products; the objective being to facilitate access to the market of new health-care interventions:

• Scientific or Medical Divisions Programs; Design of clinical - economic research and studies of Outcomes Research of products in Phases II, III and IV trials. Reports and bibliographical reviews.
• Regulatory Departments. Development of strategies and discussion on the conditions of pricing and reimbursement of the new therapeutic options, and consulting on health-care product commercialization.
• Institutional Relations and Market Access. Defining reasons surrounding therapeutic and economic value of health-care interventions.
• Commercial Departments, Sales, Marketing or Business Units. Generation of evidence that support the correct positioning and value messages of the product.